Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 27th March 2019 from 11:00 AM to 1:00 PM (GMT).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 4, 1998
Previous Article Next Article

Cancer therapy: a move to the molecular level

Abstract

The development of cancer therapeutics has traditionally been based on an empirical approach. As modern biological techniques have begun to open the way to understanding of key cellular processes at the individual protein level, it has become possible to take a more mechanistic approach to the discovery of antitumour agents. This review describes some of the areas in which target mechanisms have been identified and the drugs which have been developed or are currently being investigated. Some of the interventions are not aimed primarily at the tumour, but at the host systems.

Back to tab navigation

Article type: Paper
DOI: 10.1039/A827251Z
Citation: Chem. Soc. Rev., 1998,27, 251-261

  •   Request permissions

    Cancer therapy: a move to the molecular level

    F. Thomas Boyle and G. F. Costello, Chem. Soc. Rev., 1998, 27, 251
    DOI: 10.1039/A827251Z

Search articles by author

Spotlight

Advertisements